Office of Pharmaceutical Quality
E392785
The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Office of Pharmaceutical Quality canonical | 1 |
| U.S. Food and Drug Administration Office of the Chief Scientist | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T3849411 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Office of Pharmaceutical Quality Context triple: [Center for Drug Evaluation and Research, oversees, Office of Pharmaceutical Quality]
-
A.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
B.
ICH Q10 Pharmaceutical Quality System
ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
-
C.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
D.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
E.
ICH Q8 Pharmaceutical Development
ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Office of Pharmaceutical Quality Target entity description: The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
-
A.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
B.
ICH Q10 Pharmaceutical Quality System
ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
-
C.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
D.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
E.
ICH Q8 Pharmaceutical Development
ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
FDA office
ⓘ
regulatory organization unit ⓘ |
| abbreviation | OPQ ⓘ |
| appliesTo | human drugs ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| establishedBy |
Food and Drug Administration
ⓘ
surface form:
U.S. Food and Drug Administration
|
| focusesOn |
drug manufacturing quality
ⓘ
drug product lifecycle ⓘ pharmaceutical quality ⓘ quality risk management ⓘ quality standards for drugs ⓘ |
| goal |
promote innovation in pharmaceutical manufacturing while maintaining quality
ⓘ
provide a consistent drug quality program across all human drugs ⓘ |
| hasRole |
ensure consistency of human drugs
ⓘ
ensure drug safety related to quality ⓘ ensure pharmaceutical quality ⓘ |
| jurisdiction |
United States of America
ⓘ
surface form:
United States
|
| language | English ⓘ |
| locatedIn | Silver Spring, Maryland ⓘ |
| mission |
assure that human drugs meet appropriate quality standards throughout their lifecycle
ⓘ
ensure that quality medicines are available to the American public ⓘ |
| oversees |
drug product quality throughout lifecycle
ⓘ
implementation of quality by design principles in drug development ⓘ quality aspects of drug submissions ⓘ |
| parentOrganization |
Center for Drug Evaluation and Research
ⓘ
Food and Drug Administration ⓘ
surface form:
U.S. Food and Drug Administration
|
| partOf |
Center for Drug Evaluation and Research
ⓘ
Food and Drug Administration ⓘ
surface form:
U.S. Food and Drug Administration
|
| regulates |
brand-name drugs
ⓘ
generic drugs ⓘ human drug products ⓘ over-the-counter drugs ⓘ |
| responsibleFor |
lifecycle management of drug quality
ⓘ
oversight of pharmaceutical manufacturing ⓘ policy development on pharmaceutical quality ⓘ post-approval quality oversight ⓘ quality assessment of drug applications ⓘ quality surveillance of marketed drugs ⓘ setting quality expectations for drug products ⓘ |
| topic |
drug regulation in the United States
ⓘ
pharmaceutical quality ⓘ |
| usesApproach |
lifecycle approach to pharmaceutical quality
ⓘ
science- and risk-based quality assessment ⓘ |
| website | https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-pharmaceutical-quality ⓘ |
| worksWith |
Office of Compliance
ⓘ
Office of Generic Drugs ⓘ Center for Drug Evaluation and Research ⓘ
surface form:
Office of New Drugs
Office of Regulatory Affairs ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Office of Pharmaceutical Quality Description of subject: The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
U.S. Food and Drug Administration Office of the Chief Scientist